| Description | The A201 antibody is a recombinant antibody derived from mice, which specifically targets Human EPHA2. Although A201 also showed some binding to cells expressing EPHA4, this cross-reaction was considered insignificant in human tissues due to its weak affinity towards forced expression cells. |
| Clonality | Monoclonal |
| Host Species | Mouse |
| Target Species | Human |
| Isotype | IgG1 |
| Expression Species | HEK293F or CHO cell line |
| Conjugation | Unconjugated |
| Purity | >95% |
| Endotoxin | <1 EU/mg |
| Form | Liquid |
| Purification | Protein G purified |
| Sterility | 0.2 μM filtered |
| Formulation | PBS, pH 7.4 |
| Preservation | No preservatives |
| Stabilizer | No stabilizers |
| Storage | Store at 4°C within one or two weeks. Store at -20°C for long term. Avoid repeated freeze/thaw cycles. Refer to the COA file for specifics. |
| Application | ELISA; IHC |
| Application Notes | For immunohistochemistry (IHC) assay, the concentration of the mouse anti-EPHA2 antibody A201 should be prepared at 5 μg/mL. |
| ELISA | Enzyme-Linked Immunosorbent Assay Protocol |
| WB | Western Blot Protocol |
| FC | Flow Cytometry Protocol |
| Target | EPHA2 |
| Alternative Name | EPH Receptor A2; Tyrosine-Protein Kinase Receptor ECK; EC 2.7.10.1; ECK; Epithelial Cell Receptor Protein Tyrosine Kinase; Ephrin Type-A Receptor 2; Soluble EPHA2 Variant 1; Epithelial Cell Kinase |
| Gene ID | 1969 |
| UniProt | P29317 |
| Research Area | Cardiovascular; Neuroscience |
